Featured Pharmacovigilance Experts

I am a third-generation pharmacist with certifications in pharmacogenetics and antepartum doula care, specializing in maternal health and medication safety. After earning my PharmD from Creighton University and a BS in Hospitality from UNLV, I built a career spanning hospital and retail pharmacy, consulting, entrepreneurship, telemedicine, and medical affairs. Currently, I work as a medical science liaison while continuing to consult and practice as a hospital pharmacist. My expertise is grounded in both research and lived experience. After enduring three pregnancies complicated by Hyperemesis Gravidarum (HG), I founded HG Pharmacist® and Obstet-Rx to provide personalized medication guidance, integrate pharmacogenetics into maternal care, and advocate for women worldwide. My research includes genetic predictors of ondansetron effectiveness and recurrence risk for HG, and I have published extensively on maternal health. I also served on the HER Foundation board from 2019 to 2021 and frequently present at professional conferences. As host of the MaternalRx podcast on the Pharmacy Podcast Network, I highlight the pharmacist’s role in maternal outcomes, drawing from my background in specialty diagnostics such as preeclampsia biomarkers, iron deficiency anemia, and oncology supportive therapies. This blend of patient advocacy, clinical expertise, and medical affairs experience positions me as a trusted voice on maternal health, medication management, and the evolving role of pharmacists in healthcare. When I’m not speaking or consulting, I enjoy yoga, ice skating, and time outdoors with my dog. I welcome opportunities to collaborate with media to shed light on maternal health challenges, the importance of personalized medicine, and strategies to improve patient outcomes.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Swalin Suraj Pradhan is an independent student researcher meaning he isn't affiliated with any instituition and whose work focuses on pharmacokinetics, drug modeling, and theoretical frameworks in pharmaceutical science. He is the author of the Drug Multiplication Theory (DMI Model), a novel pharmacokinetic approach integrating drug bioavailability, effect strength, and reaction transformation coefficients. His work aims to refine how drug behavior is mathematically understood and applied in clinical pharmacology. Swalin has also published two books of poetry, showcasing his ability to balance rigorous scientific inquiry with emotional and literary depth.

Dr. Rob Taylor, Pharm.D., is a licensed pharmacist and founder of Pharm Picked, a wellness brand inspired by his mother’s battle with autoimmune disease. He helps families support immune balance with clean, pharmacist-formulated supplements for kids and adults. Rob combines science-backed care with personal purpose to create trusted solutions for autoimmune and everyday wellness.

Fresh, enthusiastic Pharmacy graduate with thorough knowledge in Pharmacology, Pharmaceutics, Medicinal Chemistry. Skilled in Pharmaceutics, Pharmacology, MS Office (Word, Excel, PowerPoint) and Management. Strong operations professional with a Bachelor of Pharmacy focused in Pharmacy from Seemanta Institute of Pharmaceutical Sciences.

I’m Dr. Giuseppe Aragona, a medical professional with over 30 years of experience in general practice, oncology, and obstetrics across Italy, the UK, and Australia. I’ve worked as a Senior Medical Officer with International SOS and EXXON Mobil, handling complex health scenarios in demanding environments. My background includes emergency care, specialist cancer treatment, and multilingual patient support, which I now apply to ensure the medical accuracy of all content I oversee.

I am a passionate believer of the triple bottom line approach, and this is complemented by my experience in both - private as well as non-profit sectors. Over 2 decades I have developed professional skills in overall management, strategy, Innovation, Impact Assessment, monitoring of community investment projects, ESG Compliances, stakeholder engagement, interpersonal communication and advocacy with the Government. One of my key abilities is to deliver projects independently and convert an idea into a high-quality finished product through assertive risk-taking and innovation. Furthermore, my commitment to accuracy, attention to detail and infectious enthusiasm allows me to be an effective team player

I am a senior technology leader with extensive experience driving digital transformation, enterprise architecture, cybersecurity and strategy across highly regulated sectors. With a proven record of leading large-scale programs ranging from tens to hundreds of millions in value, I specialize in aligning complex technology strategies with business objectives to enhance resilience and security. My leadership on transformative initiatives, including major core modernization and cybersecurity programs, exemplifies my ability to deliver secure, impactful solutions by uniting cross-functional stakeholders and managing high-stakes projects. Passionate about integrating AI and emerging technologies to drive business value, I bring a strategic, forward-looking approach that ensures technology investments deliver measurable outcomes. My leadership combines strategic oversight with a people-centred focus to build and empower high-performing teams.